SCHEMBL3484031

SCHEMBL3484031

CCOC(=O)C(C)(C)Oc1ccccc1C(CBr)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 9/20 0.47
PPARA Q07869 3/20 0.43
ABCB11 O95342 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
HTR2A P28223 1/20 0.43
PMP22 Q01453 1/20 0.43
PIN1 Q13526 1/20 0.39
PPARG P37231 2/20 0.38
MMP8 P22894 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
MDM4 O15151 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MDM2 Q00987 1/20 0.36
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4036195 0.85 ALDH1A1 (0.49) PPARACYP1A2CYP3A4PPARGL3MBTL1
SCHEMBL3485038 0.82 PPARA (0.58) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL3483713 0.79 PPARA (0.53) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL31745119 0.77 FBP1 (0.54) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4685610 0.76 FBP1 (0.53) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL3485006 0.76 FBP1 (0.55) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4111678 0.75 FBP1 (0.58) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL12670823 0.74 FBP1 (0.56) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL3484624 0.74 FBP1 (0.51) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4423002 0.73 PPARA (0.59) FBP1PPARAABCB11CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 FBP1 2382/4885PPARA 1045/4885ABCB11 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.